Patient advocates were disappointed with Sunday’s vote — Republican senators blocked the $35 insulin cap for private insurers — and expressed hope that federal and state measures could be included in legislation down the road.
Clayton McCook of Edmond, Oklahoma, is among those who support capping the cost of insulin for people with private health insurance.
A federal insulin cap for private insurance would have made “a huge difference to our family,” he said.
“This year, with an evenly divided Senate, the insulin cap for people with private insurance didn’t secure enough votes,” Neuman said.
McCook also advocated for changes besides a cap on insulin costs, saying Congress pass legislation that would lower the list price.